The Degree will provide participants with the knowledge, skills and hands-on technical expertise necessary to face the challenges of manufacturing ATMPs for clinical use. This innovative programme combines the general fundamentals of ATMP regulation with specific knowledge necessary to deal with the development of medicinal products of cell therapy, gene therapy and tissue engineering.
The programme will include:
A > Theoretical training that is composed of 11 sections that will be completed online by students at their convenience, although with continuous support from instructors through a dedicated e-learning platform that will be available on a 24/7 basis. The case method will be used throughout the online activities promoting interaction and debate with professors and other students, creating strong and lasting relationships.
B > A 1/3-week period of practical training (depending on the chosen degree) at Línea IAVANTE’s (Fundación Progreso y Salud) headquarters in Granada, Spain. This will complement the acquired theoretical knowledge by making use of a fully equipped GMP facility specifically built for training purposes and dedicated expert tutors.
C > Supervised individual work to compile an investigational medicinal product dossier or a GMP facility dossier (site master file) as final project (dissertation) of the Master, depending on the chosen Degree.
The whole programme lasts 17 months from January 2021 to June 2022. Click here to see the calendar's details